JAM
ANIP icon

JW Asset Management’s ANI Pharmaceuticals ANIP Stock Holding History

JW Asset Management’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-29,722
Closed -$1.56M – 23
2017
Q3 		$1.56M Hold
29,722
– – 1.14% 21
2017
Q2 		$1.39M Hold
29,722
– – 0.89% 21
2017
Q1 		$1.47M Hold
29,722
– – 0.31% 24
2016
Q4 		$1.8M Hold
29,722
– – 1.2% 20
2016
Q3 		$1.97M Buy
+29,722
New +$1.86M 1.36% 15
2015
Q4 		– Sell
-35,864
Closed -$1.42M – 44
2015
Q3 		$1.42M Hold
35,864
– – 0.51% 29
2015
Q2 		$2.23M Sell
35,864
-14,689
-29% -$874K 0.68% 25
2015
Q1 		$3.16M Buy
50,553
+28,029
+124% +$1.7M 1.37% 18
2014
Q4 		$1.27M Buy
+22,524
New +$993K 0.95% 22

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

JW Asset Management's ANIP Position: Q4 2017 in Review

JW Asset Management sold out of ANI Pharmaceuticals (ANIP) in Q4 2017, closing a stake of 29,722 shares — an estimated $1.56M sold.

JW Asset Management first reported a position in ANIP in Q4 2014 and held it in 9 quarters. The position peaked at $3.16M in Q1 2015. 163 funds tracked by Wall St. Rank hold ANIP as of Q4 2017.

  • JW Asset Management reported no remaining ANI Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • JW Asset Management sold 29,722 ANI Pharmaceuticals shares in Q4 2017, an estimated $1.56M.
  • JW Asset Management first reported a position in ANI Pharmaceuticals in Q4 2014 and held it in 9 quarters.
  • JW Asset Management's ANI Pharmaceuticals position peaked at $3.16M in Q1 2015.
  • 163 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q4 2017.

Based on JW Asset Management's 13F filing for Q4 2017, filed 12 Feb 2018.